Stay updated with breaking news from Matthewj Meyer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- AuraVax Therapeutics, Inc., a biotechnology company developing novel immunotherapies to prevent and treat respiratory viruses, today announced...
Share this article Share this article HOUSTON, May 25, 2021 /PRNewswire/ -- AuraVax Therapeutics, Inc. (Auravax), a biotech company developing novel intranasal therapeutics and vaccines to help patients defeat debilitating respiratory diseases, including COVID-19, today announced the formation of its inaugural Scientific Advisory Board (SAB), consisting of leading experts in the fields of biology, vaccines and intranasal drug delivery. The SAB will guide and advise the company in its ongoing development of proprietary therapeutics and vaccines for respiratory diseases. The SAB is chaired by ...
AuraVax Therapeutics Enters into Exclusive License Agreement with the University of Houston for Intranasal Vaccine and Therapeutics Technology Platform --Transaction supports development of AuraVax's lead COVID-19 intranasal program, plus other vaccines and therapeutics targeting respiratory diseases-- News provided by Share this article Share this article HOUSTON, Feb. 3, 2021 /PRNewswire/ -- AuraVax Therapeutics Inc. (www.auravax.com), a pioneering biotech company developing novel intranasal vaccines and therapies to help patients defeat debilitating diseases including COVID-19, today annou...
AuraVax Therapeutics Enters into Exclusive License Agreement with Massachusetts General Hospital for Intranasal Vaccine and Therapeutics Platform --Transaction bolsters development of AuraVax's lead COVID-19 intranasal vaccine and strengthens platform for therapeutic development targeting a range of viral infections News provided by Share this article Share this article HOUSTON, Jan. 13, 2021 /PRNewswire/ -- AuraVax Therapeutics Inc. (www.auravax.com), a biotech company developing novel intranasal vaccines and therapies to help patients defeat debilitating diseases, including COVID-19, today ...